Congenital Adrenal Hyperplasia - 2 Studies Found
| NOT_YET_RECRUITING |
: Evaluate the Safety, Efficacy, and Pharmacokinetics of CRN04894 in Participants With Congenital Adrenal Hyperplasia : : 2025-07-31 : CRN04894 is an orally active nonpeptide melanocortin 2 receptor (MC2R) or adrenocorticotropic hormone (ACTH) antagonist. |
| COMPLETED |
: A Study to Determine Eligibility for CAH-301 (A Study of Gene Therapy for Classic Congenital Adrenal Hyperplasia (CAH) [NCT04783181]) : Congenital Adrenal Hyperplasia : 2025-07-31 : No intervention given |